Post Menopausal
Mostrando 1-12 de 56 artigos, teses e dissertações.
-
1. Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy: prevalence and associated factors
ABSTRACT Objectives: To determine the prevalence of metabolic syndrome (MetS) and its associated factors in a group of HIV-infected middle-aged women. Methods: Cross-sectional study including 273 HIV-infected climacteric women of 40-60 years of age under care in two HIV outpatient reference centers in Brazil. Metabolic syndrome diagnosis was based on 2006
Braz J Infect Dis. Publicado em: 2017-06
-
2. Prevalence of metabolic syndrome in pre- and postmenopausal women
ABSTRACT Objective The objective of this study was to determine the prevalence of metabolic syndrome (MS) and its components among pre- and postmenopausal women, as well as the association between menopausal status and MS. Materials and methods A retrospective study was conducted at a reference cardiology outpatient clinic in a city located in Northweste
Arch. Endocrinol. Metab.. Publicado em: 16/02/2017
-
3. Serum 25-hydroxyvitamin D levels are associated with functional capacity but not with postural balance in osteoporotic postmenopausal women
OBJECTIVES: In post-menopausal women with osteoporosis, insufficient vitamin D levels decrease calcium fixation in the bones and calcium transport in the sarcoplasmic reticulum, which impairs muscle strength, possibly leading to detrimental consequences for the preservation of functional capacity and postural balance, fall prevention, and fracture risk. The
Clinics. Publicado em: 2017-01
-
4. Is handgrip strength normalized to body weight a useful tool to identify dynapenia and functional incapacity in post-menopausal women?
ABSTRACT Objective To investigate whether handgrip strength normalized to body weight could be a useful clinical tool to identify dynapenia and assess functional capacity in post-menopausal women. Method A total of 136 postmenopausal women were recruited. Body composition (Dual Energy X-ray Absorptiometry [DEXA], Bio-electrical Impedence Analysis [BIA]), g
Braz. J. Phys. Ther.. Publicado em: 22/09/2016
-
5. Use of Ursodeoxycholic Acid on Post-menopausal Obesity, Hepatic steatosis and Plasma Profile as an Alternative Treatment for Hormone Replacement Therapy
ABSTRACT The aim of this study was to evaluate the efficacy of the ursodeoxycholic acid (UDCA) as an alternative treatment for menopause pathologies. For this, female Swiss-CD-1 mice were ovariectomized (OVX); SHAM operated mice served as controls. Ten weeks after operation, each group of mice was treated during four weeks with either UDCA, or 17(-estradiol+
Braz. arch. biol. technol.. Publicado em: 2015-12
-
6. Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats
Drospirenone (DRSP) is a progestin with anti-aldosterone properties and it reduces blood pressure in hypertensive women. However, the effects of DRSP on endothelium-dependent coronary vasodilation have not been evaluated. This study investigated the effects of combined therapy with estrogen (E2) and DRSP on endothelium-dependent vasodilation of the coronary
Braz J Med Biol Res. Publicado em: 17/11/2015
-
7. The relationship between oestrogen and muscle strength: a current perspective
The relationship between muscle strength and oestrogen is ambiguous and is still largely unresolved. The evidence for and against an effect of oestradiol on determinants of muscle function is equivocal and often contradictory. The bulk of the research in this area was performed during the eighties and nineties, using models of reproductive functioning such a
Rev. bras. educ. fís. esporte. Publicado em: 2014-04
-
8. Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study
OBJECTIVE: To determine the safety and efficacy of a transdermal nanostructured formulation of progesterone (10%) combined with estriol (0.1%) + estradiol (0.25%) for relieving postmenopausal symptoms. METHODS: A total of 66 postmenopausal Brazilian women with climacteric symptoms of natural menopause received transdermal nanostructured formulations of pr
Clinics. Publicado em: 2014-02
-
9. Estado menopáusico e síndrome metabólica em mulheres no climatério atendidas em um ambulatório no sul do Brasil
Metabolic syndrome (MetS) is a complex disorder represented by a cluster of cardiovascular risk factors. Menopausal transition may be a key factor in the increase of prevalence of MetS.A cross-sectional study was conducted with 551 women from 40 to 65 years treated at a clinic in southern Brazil. Hysterectomized women and women who were submitted to hormone
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 2012
-
10. A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
OBJECTIVE: Differentiation between benign and malignant ovarian neoplasms is essential for creating a system for patient referrals. Therefore, the contributions of the tumor markers CA125 and human epididymis protein 4 (HE4) as well as the risk ovarian malignancy algorithm (ROMA) and risk malignancy index (RMI) values were considered individually and in comb
Clinics. Publicado em: 2012
-
11. Efeitos da suplementação de zinco e do treinamento físico sobre o controle de peso e o metabolismo glicêmico em ratas ovariectomizadas
It is common to observe menopausal metabolic disorders that lead to weight gain and changes in glycemic control. Physical activity and zinc supplementation have been suggested as interventions to prevent weight gain and glucose metabolism disorders. Thus, this study aims to assess the effects of physical training and zinc supplementation on carbohydrate meta
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 2012
-
12. Densidade mineral óssea em usuárias e ex-usuárias do contraceptivo injetável com acetato de medroxiprogesterona de depósito / Bone mineral density in users or ex-users of the injectable contraceptive depot medroxyprogesterone acetate
Objectives: Assess bone mineral density (BMD) in users for at least a year and ex-users in injectable contraceptive postmenopausal with medroxyprogesterone acetate depot (DMPA). Subjects and methods: Two studies have been conducted, both transversal cutting with current users of reproductive age of DMPA and another with postmenopausal women who have used DMP
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 06/12/2011